Large-capacity Newcastle disease live vaccine 'Poulshot ND Max' launched

Published Feb 2, 2026

Tridge summary

[Livestock News Reporter Kim Young-gil] The Central Vaccine Research Institute (CEO Yoon In-jung) has launched a high-capacity 5,000 titer New Castle Disease (ND) live vaccine, 'Poulshot ND Max'. 'Poulshot ND Max' has increased the capacity from the previous 2,000 titer product to 5,000 titers. This not only reduces the volume and weight of the vaccine but also decreases the disposal rate of empty bottles after vaccine use by approximately 60%. 'Poulshot ND Max' is a long

Original content

[Livestock News, Kim Young-gil Reporter] The Central Vaccine Research Institute (Representative Yoon In-jung) has launched a high-capacity 5,000-dose Newcastle Disease (ND) live vaccine, 'Poulshot ND Max'. 'Poulshot ND Max' has increased the capacity from the previous 2,000 doses to 5,000 doses. This not only reduces the volume and weight of the vaccine but also decreases the disposal rate of empty bottles after vaccine use by approximately 60%. 'Poulshot ND Max' incorporates an enterotrophic Newcastle Disease vaccine strain that acts briefly on the respiratory system and acts longer in the digestive system (intestines), significantly reducing respiratory stress. The Central Vaccine Research Institute stated, ...
Source: Chuksannews

Would you like more in-depth insights?

Gain access to detailed market analysis tailored to your business needs.
By clicking “Accept Cookies,” I agree to provide cookies for statistical and personalized preference purposes. To learn more about our cookies, please read our Privacy Policy.